Facilitating Access to Approved Medication
Get Access To Decitabine Injection 50 mg
Decitabine Injection has EU approval for acute myeloid leukemia (AML).
The FDA approved the drug Decitabine in 2006.
Decitabine Injection
- Generic Brand Name – On Request
- Innovator Brand Name – On Request
- API – Decitabine
- Packaging – Single-Use Vial
- Strength – 50mg
- Manufacturer Name – Celon Labs
What is decitabine used for?
Decitabine Injection is a nucleoside metabolic inhibitor indicated in order to treat patients with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Disclaimer
All Trademarks and Brands that appear on website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.
Get Access To Decitabine Injection 50 mg
Shreyaansh Lifesciences, Jaipur. India
Shreyaansh Lifesciences is registered in Jaipur, India. Registration Number : 08AEEFS9350K1ZI under GST Act.
Branch Offices in India : Jaipur | New Delhi
SF-72-73 2ND FLOOR, Jaipur Electronic Market, Ridhi Sidhi Choraha, Jaipur, Rajasthan, 302018.
+91 99292 77766
Facts of Medicines
The recommended dose should be administered as an injection into the vein under the supervision of a healthcare practitioner. Your healthcare practitioner will determine what dose is appropriate and how often you need to receive it.
DECITABINE SIDE EFFECTS
Most common adverse reactions include cough, fatigue, neutropenia, hyperglycemia, thrombocytopenia, nausea, anemia, pyrexia, petechiae, constipation, and diarrhea.
STORAGE AND HANDLING
Care should be exercised in the handling of MYLODEC. MYLODEC injections should not be opened or broken. Store vials at 25°C (77°F); excursions permitted to 15 to 30°C (59-86°F).
WARNINGS AND PRECAUTIONS
- Liver chemistries and serum creatinine needs to be obtained before initiation of decitabine 50 mg treatment.
- Platelet counts and complete blood counts should be performed as required in order to monitor response as well as toxicity, but at a minimum, before each cycle.
- Women of the childbearing potential should be apprised to avoid becoming pregnant while taking treatment with decitabine 50 mg.
- Male patients should be apprised not to father a child during treatment with this medication, and for 2-months after finishing the treatment.
- Following administration of the recommended decitabine dosage for the 1st cycle, treatment for the subsequent cycles need to be adjusted.
- Myelosuppression and worsening neutropenia may occur a bit frequently in the 1st or 2nd treatment cycles, and may not necessarily show progression of the underlying MDS.
- Mylodec always should be used with the extra caution in patients with renal and hepatic impairment.
FAQs – Medicine Questions
Is Decitabine an FDA-approved drug?
What are the alternate brands of Decitabine Injection?
How does Decitabine work?
Where can I buy Decitabine injection?
You can buy Decitabine injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.
The buyer should check the existing law in their home country before importing the product.
What is the procedure to buy Decitabine?
Patients can simply fill the order form or can send mail at info@treatmentoptions4u.com. Patients can also send WhatsApp messages to +91 98738 10020. We will reply ASAP with the details of the Decitabine Injection price as well as procurement procedure.
Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.
How to store Decitabine?
NEWS / UPDATES
- Janssen-Cilag International NV, Electronic medicines compendium (emc), [ Revised on March 2019] [ Accessed on 9th April], https://www.medicines.org.uk/emc/files/pil.2838.pdf
- Otsuka America Pharmaceutical, US Food and Drug Administration, [ Revised on December 2018] [ Accessed on 9th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021790s021lbl.pdf
- Michael Daskalakis et al; Decitabine; Recent Results in cancer Research 2010; Accessed 09/042021; https://pubmed.ncbi.nlm.nih.gov/20072836/